Welcome Guest
Sign In
Register
Home
Analytical Testing
Clinical Trials
Contract Research
Logistics
Manufacturing
Articles
Facility Tours
News
Events
Videos
Clinical Trials Documentary
A Solid Dosage Future Documentary
Whitepapers/App Notes
Issue Archives
Company Focus
Service Directory
Register
Sign In
Home
Clinical Trials
Product and Service Directory
Clinical Trial Development Services and Outsourcing
Contract Research Organizations / Contract Research Services (CRO Services)
Preclinical Contract Research / Preclinical Research Services (Preclinical CRO)
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Pharmacology Services
Preclinical Drug Efficacy Testing and Modeling Services
Preclinical Pharmaceutical Screening Services
Preclinical Pharmacology Services by Therapy Type
Preclinical Cancer Pharmacology / Oncology Pharmacology Services
Preclinical Cardiovascular Pharmacology Services
Preclinical Diabetes Pharmacology Services
Preclinical Inflammation Pharmacology Services
Preclinical Multiple Sclerosis Pharmacology Services
News
ProBio Licenses Antibody Asset to AbTis for ADC Development
Thursday, November 12, 2026
ProBio has entered into an exclusive global licensing agreement with AbTis, a South Korean biotechnology company and subsidiary of Dong-A ST specializing in site-specific conjugation technologies for antibody-drug conjugates.
read more
Toxys, Charles River Expand Toxicology Collaboration
Thursday, November 12, 2026
Toxys and Charles River Laboratories have announced an expanded collaboration to broaden access to ToxTracker and ReproTracker, two New Approach Methodologies for genotoxicity and developmental toxicity assessment
read more
Lonza Names Bertha Steinmetz Vilela CHRO
Thursday, November 12, 2026
Lonza has appointed Bertha Steinmetz Vilela as Chief Human Resources Officer, Executive Vice President and member of the Executive Committee, effective January 1, 2027. She succeeds Nicoleta Baumgärtner, who has served as CHRO and Executive Committee member since 2024 and decided to pursue a new ...
read more
Charles River to Buy Frontage Bioanalysis Business for $470M
Thursday, November 12, 2026
Charles River Laboratories has entered into definitive agreements to acquire Frontage Holdings' bioanalysis and DMPK operations in Exton, Pennsylvania, for approximately $470 million in cash, subject to customary closing adjustments.
read more
Codis Rapid Screen: Transforming Poor Solubility into a Clear Development Strategy
Tuesday, November 10, 2026
Discover how a molecule-led, technology-agnostic framework identifies the dominant solubility constraint and selects the right enabling technology before early PK studies.
read more
More News
Featured Videos
A Solid Dosage Future
In the pharmaceutical manufacturing space, while biopharmaceuticals often dominate discussions, it's crucial to acknowledge the enduring significance of solid dosage products (e.g., tablets, capsules, pills). These traditional forms remain the ...
Pharma Flash - Biopharm Facility News and Regulatory Updates in this Week’s ...
Check out the top pharma news of the week from our Editor-In-Chief, Mike Auerbach. Watch video: Eli Lilly Chooses Vendor for Single-Use Facility and FDA Approves OTC oral contraceptive plus more news in this week’s Pharma Flash
More Videos
Featured Products and Services
We're sorry, no matching articles were found. Please select different filter options and try your search again.
More Featured Products
Featured Articles
We're sorry, no matching articles were found. Please select different filter options and try your search again.
Subscriptions
Get started here for your complimentary print or digital subscription
Sign up Now »